NewLink Genetics (NLNK) Posts Q2 Loss of 49c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to NewLink Genetics (NLNK) Posts Q2 Loss of 49c/Share

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results

July 31, 2015 7:00 AM EDT

AMES, Iowa, July 31, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company at the forefront of developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer, today reported consolidated financial results for the second quarter of 2015 and progress in its clinical and business development programs.

NewLink Genetics continues to drive forward, and to execute on, its strategy of developing treatment options for patients with cancer using targeted immune response and disruptive checkpoint blockade, said Dr. Charles Link, Chairman and Chief Executive Officer.  We have seven product candidates... More